Tumor-Infiltrating Lymphocyte (TIL) therapy

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Tumor-Infiltrating Lymphocyte (TIL) therapy

Apr 3, 2024, 15:42 | Drugs

Jarushka Naidoo: Phase II trial of Tumor-Infiltrating Lymphocyte (TIL) therapy (Lifileucel) in Advanced Non-Small Cell Lung Cancer post Immunotherapy with or without chemotherapy

All: 1 Posts: 1 - 100

Radiotherapy for Anus Cancer: Types, Success Rate, Side Effects And More

World Association for Integrative Oncology (WAIO) and OncoDaily Announce Strategic Partnership to Advance Holistic Cancer Care

Leukemia: Symptoms, Causes, Types, Diagnosis & Treatment

U.S. FDA Approval of Ziihera for the Previously Treated, Unresectable or IHC 3+ Biliary Tract Cancer

ASCO GI 2025 - Everything You Need To Know About Biggest Gastrointestinal cancer Symposium

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023